Zdrowie i gospodarka · 29/09/2023
FDA Announces Draft Guidance for Industry on Graft-Versus-Host Diseases Prevention and Treatment
The US Food and Drug Administration (FDA) has released a draft guidance document to help pharmaceutical companies develop drugs, biological products, and devices to prevent or treat acute and chronic graft-versus-host diseases (aGVHD and cGVHD), a serious complication of stem cell transplants.